Scientists of the Ural Federal University are working on a project of the targeted drugs delivery for the diagnosis and treatment of malignant tumors. To make this process more efficient, it is planned to develop new luminescent molecular carriers and organic fluorescent nanosized particles. The project was supported by the Russian Science Foundation, which allocated a three-year grant in the amount of 4 to 6 million rubles per year.
“Fluorescence is the absorption of a quantum of light by a substance, followed by the emission of another quantum that has properties that are different from the original. This is a bewitching phenomenon that we encountered in our research,” explains Natalia Belskaya, project manager, professor of UrFU. – We are actively studying the physics of this phenomenon, mastering the methods of its study and prospects for use. And substances with such unique photophysical properties are of great interest due to a wide range of applications, for example, as biomolecular labels or probes for research in biology, medical diagnostics. In addition, it is an important component of modern methods of treatment of socially significant diseases, which, in the first place, include malignant tumors.” ...
The full text of the news can be found at GMPnews.Net